Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome.
The authors report a case of a 65-year-old woman with small cell lung cancer who had profound, progressive lower extremity weakness, intermittent blurred vision, a dry mouth, and orthostatic hypotension. Results of laboratory and electrodiagnostic studies were consistent with the diagnosis of Lambert-Eaton myasthenic syndrome. The patient was treated with one course of intravenous immunoglobulin and had significant improvement.
Peterlin
B Lee
BL
Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.
Flood
William
W
Kothari
Milind J
MJ
D000200:Action Potentials; D000368:Aged; D018288:Carcinoma, Small Cell / Q000150:complications; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D015624:Lambert-Eaton Myasthenic Syndrome / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008175:Lung Neoplasms / Q000150:complications; D008475:Median Nerve / Q000503:physiopathology
D016756:Immunoglobulins, Intravenous